Raelipskie Partnership X4 Pharmaceuticals, Inc Transaction History

Raelipskie Partnership

  • $195 Billion
  • Q1 2025

A detailed history of Raelipskie Partnership transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Raelipskie Partnership holds 1,000 shares of XFOR stock, worth $2,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$2,300
Previous $734,000 67.85%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

May 23, 2024
BUY
$0.61 - $0.99 $610 - $990
1,000 New
1,000 $839,000

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $158M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Raelipskie Partnership Portfolio

Follow Raelipskie Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raelipskie Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Raelipskie Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email